Discovery

Explore Topics Papers

Docs Terms Privacy

Search Kritoma

Recent searches

Searches you run from this bar will appear here.

CAR-T and engineered T cell therapies

Clinical MedicineUpdated Oct 5, 2026Version v1

Knowledge Timeline Gaps (1)Evidence (307)Community (0)

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

307 papers

SearchSort evidence

All307 Core249 Supporting83 Background0

Showing 133-144 of total 307 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedDirectly related

CAR transgenic T-cell lymphoproliferative neoplasm (CTTLN): malignant transformation of cellular immunotherapy.

Baumgartner F; Dickinson MJ; Blombery P

Jan 1, 2026Blood

2026PubMedDirectly related

Polyaspartamide-Mediated Messenger RNA Delivery Enables Efficient Ex Vivo Engineering of Chimeric Antigen Receptor Natural Killer Cells via Enhanced Cellular Internalization.

Park HY; Kim S; Kim K; Min S; Kang H; Lee CE; Kim S; Choi SS; Kwon S; Kim ES; Kim K; Kim HJ

Jan 1, 2026ACS applied materials & interfaces

2026PubMedSupporting evidence

Parallel processing of T cells and natural killer cells to enhance in vivoCAR T cell activity against blood and solid cancers.

Dobson LJ; Marron PW; Drabble AH; Liyanage TD; Pe KC; Slaney CY; Hock BD; McLellan AD

Jan 1, 2026Clinical & translational immunology

2026PubMedDirectly related

Delivery of CAR T Cells in a Magnesium-Functionated Hydrogel Boosts Peritoneal Metastasis Treatment.

Li J; Liu X; Ren E; Liao Z; Zhang H; Qiu Q; Shi J; Gong X; Lv W; Gu Z; Li H

Jan 1, 2026ACS applied materials & interfaces

2026PubMedDirectly related

Umbilical cord blood-derived CAR-NK cells: an emerging off-the-shelf platform for cancer immunotherapy.

Lu K; Cai ML; Li J; Li T

Jan 1, 2026International journal of hematology

2026PubMedDirectly related

Clinical evidence on non-viral CAR-T cell therapies for solid tumors: a scoping review.

Varón Suárez F; Moreno J; Arias-Valderrama O; Baena J

Jan 1, 2026Frontiers in immunology

2026PubMedDirectly related

CAR T Cell Therapy in Lung Cancer: Overcoming Tumor Microenvironment-Mediated Barriers.

Liu L; Liang D; Wang C; Li J; Tang J; Li W; Yu X

Jan 1, 2026International journal of biological sciences

2026PubMedDirectly related

A proposal of good manufacturing practices (GMP) laboratory for CAR T-cell therapy in Latin America and the Caribbean: challenges and opportunities.

Cabrera-Salcedo SC; Parra-Lara LG; Fernandes-Pineda M; Toro-Pedroza A; Hincapie JSV; Rios-Serna LJ; Loukanov A; Ortiz-Guzman J; Garcia-Robledo JE; Cañas CA; Cruz-Suarez GA; Osorio FO; Gustafson MP; Restrepo JG; Mosquera A; Hoyos V; Baena JC

Jan 1, 2026Frontiers in public health

2026PubMedDirectly related

Supramolecular immunomodulatory hydrogelator potentiates CAR-T therapy with long-lasting endogenous immunity toward solid tumor eradication.

Jiang C; Tang M; Guo M; Shang Q; Chen Q; An X; Xie J; Zheng K; Feng B; Wang F

Jan 1, 2026Science advances

2026PubMedDirectly related

The Modular CAR: Adapting T Cells without Reengineering Them.

Ang MJY; Luo Z; Mitchell MJ

Jan 1, 2026Cancer immunology research

2026PubMedDirectly related

Recent advances in cell therapy for AML/MDS.

Yokoyama H

Jan 1, 2026International journal of hematology

2026PubMedDirectly related

Ultrasound controllable and antigen-independent killing via cis-activating CAR T cells.

Zhu L; Cui J; Man CW; Mouchawar A; Yu X; Huang Y; Wu Y; Guo T; Xu H; Liu L; Wang Y

Jan 1, 2026Molecular therapy. Oncology

Page 12 of 26Showing 133-144 of total 307 results.

1...111213...26

CAR-T and engineered T cell therapies — Research Evidence and Topic Memory | Kritoma